Merck KGaA
MKGAF
$142.89
-$0.11-0.08%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 756.72M | 371.35M | 1.05B | 739.97M | 773.79M |
| Total Depreciation and Amortization | 556.01M | 444.68M | 535.45M | 492.56M | 477.87M |
| Total Amortization of Deferred Charges | -- | 126.89M | -- | -- | -- |
| Total Other Non-Cash Items | -18.48M | 487.76M | -203.43M | 27.24M | 34.52M |
| Change in Net Operating Assets | -355.52M | 72.17M | 388.15M | -616.27M | -701.28M |
| Cash from Operations | 938.73M | 1.50B | 1.77B | 643.50M | 584.89M |
| Capital Expenditure | -520.20M | -488.92M | -441.92M | -340.48M | -512.07M |
| Sale of Property, Plant, and Equipment | 10.79M | 16.30M | 3.51M | 2.27M | 5.47M |
| Cash Acquisitions | -56.23M | 5.82M | -3.41B | -2.27M | -210.50K |
| Divestitures | -688.60K | -17.46M | 502.72M | -- | -- |
| Other Investing Activities | -300.44M | -194.40M | -296.95M | 178.18M | 65.77M |
| Cash from Investing | -866.77M | -678.67M | -3.64B | -162.29M | -441.04M |
| Total Debt Issued | -- | 7.81B | 2.76B | 855.00M | -- |
| Total Debt Repaid | -57.60M | -8.02B | -51.00M | -110.00M | -1.56B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.61M | 0.00 | -- | -1.13B | -48.41M |
| Other Financing Activities | 9.40M | 0.00 | -1.00M | -9.00M | -200.00K |
| Cash from Financing | -70.92M | -244.46M | 3.16B | -291.68M | -1.69B |
| Foreign Exchange rate Adjustments | 2.87M | -11.64M | -24.55M | -6.81M | -41.88M |
| Miscellaneous Cash Flow Adjustments | 114.80K | 1.16M | -- | -- | -- |
| Net Change in Cash | 4.02M | 569.24M | 1.27B | 182.72M | -1.59B |